与 (R) 卡结合的1,2,3-triazoles作为新的潜在抗癌剂
Ali Oubella1, Manal A Alossaimi2, Yassine Riadi2
1Laboratory of Organic & Physical Chemistry, Applied Bioorganic Chemistry Team, Faculty of Sciences, Iboun Zohr University, Agadir, Morocco.
新型 thiazolidinone-1,2,3-triazole 混合物显示出显著的抗癌作用. 化合物6f通过caspase-3/7通路诱导亡,为新的癌症治疗提供了潜力.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 癌症生物学 癌症生物学
背景情况:
- 癌症仍然是全球主要的死亡原因,需要开发新的治疗药物.
- thiazolidinone 和 triazole 支架因其多样化的生物活性而闻名,包括抗癌性质.
研究的目的:
- 为了合成和评估新型 thiazolidinone-1,2,3-triazole 杂交物,以检测它们的细胞毒性和亡效应.
- 研究有前途的化合物对特定癌症细胞系的作用机制.
主要方法:
- 使用NMR和HRMS合成和结构性表征 thiazolidinone-1,2,3-triazole 杂交物.
- 在体外对HT-1080,A-549和MDA-MB-231癌细胞系进行抗癌查.
- 通过caspase-3/7通路和in silico分析进行亡诱导研究.
主要成果:
- 化合物6f和6g对测试的癌症细胞系表现出显著的抗瘤潜力.
- 化合物6f通过caspase-3/7通路演示了亡诱导.
- 在研究中,发现化合物6f是酶-3和酶-7的强有力的抑制剂.
结论:
- 铁利丁-1,2,3-三醇杂交物具有作为抗癌剂的治疗潜力.
- 化合物6f代表了开发新型癌症治疗策略的有前途的头.
- 基于 (R-Carvone) 的衍生品需要进一步研究它们的临床应用.
更多相关视频
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
06:34Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS
Published on: June 20, 2014
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Inhibition of Cdk Activity
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
